PRECISE is a cornerstone of our remote care ecosystem that was already recognized by HealthCare Outlook 2017, TMC Innovation Institute, Web Summit, TechCrunch Disrupt and many others.
(PRWEB) December 19, 2017
Did you know that 51% of ECG interpretations are wrong? This staggering average number spells millions of incorrect diagnoses and wrong treatments. The root of the problem is the manual approach to ECG interpretation. Imprecise, time-consuming and extremely prone to errors, it holds back clinics and medical professionals from maintaining high standards and reaching new frontiers.
Thankfully, more clinics each day switch to PRECISE — an Automated Cloud ECG Interpretation System, which makes cardio diagnostics 2x more accurate, 10x faster, 7x more informative and 20x cheaper. Now, clinics can save more people's lives and drastically improve the quality of medical services, while earning more money. PRECISE analyses ECG readings by over 700 parameters and delivers a fully detailed interpretation in less than 90 seconds. Reports are based on the standardized Minnesota Code and Heart Rate Variability Analysis.
PRECISE was developed by Planexta Inc., the biotech company which recently won two CES Innovation Awards. And now they again make history by boldly offering everyone an open validation of PRECISE on a huge database of over 20.000 ECG samples.
“PRECISE Cloud ECG Interpretation System brings a whole cluster of innovations together all at once” — says Eugene Nayshtetik, the President of Planexta Inc. “The accuracy of annotation is drastically increased — for the good of humanity, since PRECISE makes possible to provide the highest accuracy of diagnosis even in the remotest places. In our database we collected examples of ECG abnormalities from all 9 sections of the Minnesota code. And accumulated massive pool of the sample ECGs to prove how accurate and reliable PRECISE is. Now we invite everyone to test it.”
Irene Brinker, CEO, and Co-founder of SenceTech: “PRECISE is a cornerstone of our remote care ecosystem that was already recognized by HealthCare Outlook 2017, TMC Innovation Institute, Web Summit, TechCrunch Disrupt and many others. We look forward to developing different solutions in order to mitigate up to 80% of CV risks.”
PRECISE gives doctors 100% fully automated ECG interpretation, with great-looking adjustable reports and powerful visualization tools. It frees for doctors valuable time from the mundane routine of manual measurement while completely eliminating human error. It supports all main ECG formats. Integrates into a hospital information system without any setup fees. And reduces the cost of ECG interpretation from $20 on average to just $0.99 per unit!
The PRECISE Cloud is available for open validation at https://www.precisecloud.online
About the Company
Planexta Inc. is a quickly growing biotech company responsible for the development of several novel technologies. The company was founded by medical software and hardware engineers, who implemented innovative technologies at Mayo Clinic, The John Hopkins Hospital, Mount Sinai Hospital and a number of clinics in Alaska.
Planexta Inc. holds two 2017 CES Innovations Awards for the world’s first one wrist ECG band. The company also invented the world’s first medical-grade cuffless blood pressure monitor for one wrist.